These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4358124)

  • 1. The two sites of penicillin action in Escherichia coli.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Dec; 128(6):791-4. PubMed ID: 4358124
    [No Abstract]   [Full Text] [Related]  

  • 2. Light and electron microscopy of the early response of Escherichia coli to a 6beta-amidinopenicillanic acid (FL 1060).
    Melchior NH; Blom J; Tybring L; Birch-Andersen A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Aug; 81(4):393-407. PubMed ID: 4358286
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.
    Berenguer J; de Pedro MA; Vázquez D
    Antimicrob Agents Chemother; 1982 Feb; 21(2):195-200. PubMed ID: 6280596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An extracellular penicillinase controlled by an R factor].
    Romero E; Perduca M
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):204-10. PubMed ID: 4605499
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Aug; 128(2):211-22. PubMed ID: 4579140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity to FL 1060 (mecilliman) of E. coli and Klebsiella pneumoniae isolated from bile (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1980 Mar; 33(3):329-32. PubMed ID: 6249943
    [No Abstract]   [Full Text] [Related]  

  • 7. FL 1060: a new beta-lactam antibiotic with novel properties.
    Greenwood D; O'Grady F
    J Clin Pathol; 1973 Jan; 26(1):1-6. PubMed ID: 4348402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formation of Escherichia coli resistance to amidine penicillin].
    Zapasnik M; Morris-Rostkowska W; Chojnowski W
    Acta Pol Pharm; 1976; 33(5):663-4. PubMed ID: 187015
    [No Abstract]   [Full Text] [Related]  

  • 10. Escherichia coli resistance to beta-lactam antibiotics through a decrease in the affinity of a target for lethality.
    Spratt BG
    Nature; 1978 Aug; 274(5672):713-5. PubMed ID: 209344
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
    Zaremba M; Zukowska-Nytko K; Borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hetacillin: microbiological activity in vitro].
    Ravagnan L; Dominici A; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Sep; 7(3):187-98. PubMed ID: 4337877
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic effect of cephalexin with mecillinam.
    Otsuki M
    J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM; Seetulsingh P
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of protein synthesis inhibition on the induction of cell lysis in Escherichia coli by mecillinam plus nocardicin A.
    Berenguer J; de Pedro MA; Vázquez D
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1070-2. PubMed ID: 6297386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferable drug resistance in Neisseria gonorrhoeae.
    Mittal V; Bhujwala RA; Shriniwas ; Pandhi RK
    Indian J Med Res; 1986 Sep; 84():252-4. PubMed ID: 3102361
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
    Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
    Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
    [No Abstract]   [Full Text] [Related]  

  • 18. Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
    Barbour AG; Mayer LW; Spratt BG
    J Infect Dis; 1981 Jan; 143(1):114-21. PubMed ID: 6260864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
    Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F
    J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002
    [No Abstract]   [Full Text] [Related]  

  • 20. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.